Fuchsberger C., Flannick J., Teslovich T.M., Mahajan A., Agarwala V., Gaulton K.J., Ma C., Fontanillas P., Moutsianas L., McCarthy D.J., Rivas M.A., Perry J.R.B., Sim X., Blackwell T.W., Robertson N.R., Rayner N.W., Cingolani P., Locke A.E., Tajes J.F., Highland H.M., Dupuis J., Chines P.S., Lindgren C.M., Hartl C., Jackson A.U., Chen H., Huyghe J.R., van de Bunt M., Pearson R.D., Kumar A., Müller-Nurasyid M., Grarup N., Stringham H.M., Gamazon E.R., Lee J., Chen Y., Scott R.A., Below J.E., Chen P., Huang J., Go M.J., Stitzel M.L., Pasko D., Parker S.C.J., Varga T.V., Green T., Beer N.L., Day-Williams A.G., Ferreira T., Fingerlin T., Horikoshi M., Hu C., Huh I., Ikram M.K., Kim B.J., Kim Y., Kim Y.J., Kwon M.S., Lee J., Lee S., Lin K.H., Maxwell T.J., Nagai Y., Wang X., Welch R.P., Yoon J., Zhang W., Barzilai N., Voight B.F., Han B.G., Jenkinson C.P., Kuulasmaa T., Kuusisto J., Manning A., Ng M.C.Y., Palmer N.D., Balkau B., Stančáková A., Abboud H.E., Boeing H., Giedraitis V., Prabhakaran D., Gottesman O., Scott J., Carey J., Kwan P., Grant G., Smith J.D., Neale B.M., Purcell S., Butterworth A.S., Howson J.M.M., Lee H.M., Lu Y., Kwak S.H., Zhao W., Danesh J., Lam V.K.L., Park K.S., Saleheen D., So W.Y., Tam C.H.T., Afzal U., Aguilar D., Arya R., Aung T., Chan E., Navarro C., Cheng C.Y., Palli D., Correa A., Curran J.E., Rybin D., Farook V.S., Fowler S.P., Freedman B.I., Griswold M., Hale D.E., Hicks P.J., Khor C.C., Kumar S., Lehne B., Thuillier D., Lim W.Y., Liu J., van der Schouw Y.T., Loh M., Musani S.K., Puppala S., Scott W.R., Yengo L., Tan S.T., Taylor H.A. Jr., Thameem F., Wilson G.Sr., Wong T.Y., Njølstad P.R., Levy J.C., Mangino M., Bonnycastle L.L., Schwarzmayr T., Fadista J., Surdulescu G.L., Herder C., Groves C.J., Wieland T., Bork-Jensen J., Brandslund I., Christensen C., Koistinen H.A., Doney A.S.F., Kinnunen L., Esko T., Farmer A.J., Hakaste L., Hodgkiss D., Kravic J., Lyssenko V., Hollensted M., Jørgensen M.E., Jørgensen T., Ladenvall C., Justesen J.M., Käräjämäki A., Kriebel J., Rathmann W., Lannfelt L., Lauritzen T., Narisu N., Linneberg A., Melander O., Milani L., Neville M., Orho-Melander M., Qi L., Qi Q., Roden M., Rolandsson O., Swift A., Rosengren A.H., Stirrups K., Wood A.R., Mihailov E., Blancher C., Carneiro M.O., Maguire J., Poplin R., Shakir K., Fennell T., DePristo M., de Angelis M.H., Deloukas P., Gjesing A.P., Jun G., Nilsson P., Murphy J., Onofrio R., Thorand B., Hansen T., Meisinger C., Hu F.B., Isomaa B., Karpe F., Liang L., Peters A., Huth C., O’Rahilly S.P., Palmer C.N.A., Pedersen O., Rauramaa R., Tuomilehto J., Salomaa V., Watanabe R.M., Syvänen A.C., Bergman R.N., Bharadwaj D., Bottinger E.P., Cho Y.S., Chandak G.R., Chan J.C.N., Chia K.S., Daly M.J., Ebrahim S.B., Langenberg C., Elliott P., Jablonski K.A., Lehman D.M., Jia W., Ma R.C.W., Pollin T.I., Sandhu M., Tandon N., Froguel P., Barroso I., Teo Y.Y., Zeggini E., Loos R.J.F., Small K.S., Ried J.S., DeFronzo R.A., Grallert H., Glaser B., Metspalu A., Wareham N.J., Walker M., Banks E., Gieger C., Ingelsson E., Im H.K., Illig T., Franks P.W., Buck G., Trakalo J., Buck D., Prokopenko I., Mägi R., Lind L., Farjoun Y., Owen K.R., Gloyn A.L., Strauch K., Tuomi T., Kooner J.S., Lee J.Y., Park T., Donnelly P., Morris A.D., Hattersley A.T., Bowden D.W., Collins F.S., Atzmon G., Chambers J.C., Spector T.D., Laakso M., Strom T.M., Bell G.I., Blangero J., Duggirala R., Tai E.S., McVean G., Hanis C.L., Wilson J.G., Seielstad M., Frayling T.M., Meigs J.B., Cox N.J., Sladek R., Lander E.S., Gabriel S., Burtt N.P., Mohlke K.L., Meitinger T., Groop L., Abecasis G., Florez J.C., Scott L.J., Morris A.P., Kang H.M., Boehnke M., Altshuler D., McCarthy M.I. 2016. The genetic architecture of type 2 diabetes. Nature. 536 (7614), 41‒47.
Article CAS PubMed PubMed Central Google Scholar
Li R., Zhu H., Luo Y. 2016. Understanding the functions of long non-coding RNAs through their higher-order structures. Int. J. Mol. Sci. 17 (5), 702.
Article PubMed PubMed Central Google Scholar
Alfaifi M., Ali Beg M.M., Alshahrani M.Y., Ahmad I., Alkhathami A.G., Joshi P.C., Alshehri O.M., Alamri A.M., Verma A.K. 2021. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus. BMJ Open Diabetes Res. Care. 9 (1), e001821.
Article PubMed PubMed Central Google Scholar
López-Noriega L., Rutter G.A. 2021. Long non-coding RNAs as key modulators of pancreatic β-cell mass and function. Front. Endocrinol. (Lausanne). 11, 610213.
Xiong L., Gong Y., Wu L., Li J., He W., Zhu X., Xiao H. 2020. LncRNA-MALAT1 is involved in lipotoxicity-induced ß-cell dysfunction and the therapeutic effect of exendin-4 via Ptbp1. Endocrinology. 161 (7), bqaa065. https://doi.org/10.1210/endocr/bqaa065
Noh J.H., Kim K.M., McClusky W.G., Abdelmohsen K., Gorospe M. 2018. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip. Rev. RNA. 9 (3), e1471. https://doi.org/10.1002/wrna.147
Article PubMed PubMed Central Google Scholar
Novikova LB., Gareev IF., Raskurazhev A.A., Beylerli O.A., Minibaeva G.M. 2020. The role of long noncoding RNA in ischemic stroke. Ann. Klin. Eksp. Nevrol. 14 (1), 70–77.
Sohrabifar N., Ghaderian S., Alipour P.S., Ghaedi H., Jafari H. 2022. Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus. Arch. Physiol. Biochem. 128 (5), 1308‒1315.
Article CAS PubMed Google Scholar
Lu Q., Guo P., Liu A., Ares I., Martínez-Larrañaga M.R., Wang X., Anadón A., Martínez M.A. 2021. The role of long noncoding RNA in lipid, cholesterol, and glucose metabolism and treatment of obesity syndrome. Med. Res. Rev. 41 (3), 1751‒1774.
Article CAS PubMed Google Scholar
Chen X., Gao Y., Li D., Cao Y., Hao B. 2017. L-ncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma. J. Cell Biochem. 118 (12), 4897‒4904.
Article CAS PubMed Google Scholar
Li T., Tong H., Zhu J., Qin Z., Yin S., Sun Y., Liu X., He W. 2022. Identification of a three-glycolysis-related lncRNA signature correlated with prognosis and metastasis in clear cell renal cell carcinoma. Front. Med. (Lausanne). 8, 777507.
Russo S., Kwiatkowski M., Govorukhina N., Bischoff R., Melgert B.N. 2021. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: The importance of metabolites. Front. Immunol. 12, 74615.
Li C., Su F., Liang Z., Zhang L., Liu F., Fan W., Li Z. 2022. Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of l-ncRNA expression. Mol. Immunol. 144, 16‒25.
Article CAS PubMed Google Scholar
Yang Z., Yu G.L., Zhu X., Peng T.H., Lv Y.C. 2022. Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders. Genes Dis. 9 (1), 51‒61.
Braga E.A., Fridman M.V., Moscovtsev A.A., Filippova E.A., Dmitriev A.A., Kushlinskii N.E. 2020. Ln-cRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int. J. Mol. Sci. 21 (22), 8855.
Article CAS PubMed PubMed Central Google Scholar
Cremer S., Michalik K.M., Fischer A., Pfisterer L., Jaé N., Winter C., Boon R.A., Muhly-Reinholz M., John D., Uchida S., Weber C., Poller W., Günther S., Braun T., Li D.Y., Maegdefessel L., Perisic Matic L., Hedin U., Soehnlein O., Zeiher A., Dimmeler S. 2019. Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation. 139 (10), 1320‒1334.
Article CAS PubMed Google Scholar
Che F., Han Y., Fu J., Wang N., Jia Y., Wang K., Ge J. 2021. LncRNA MALAT1 induced by hyperglycemia promotes microvascular endothelial cell apoptosis through activation of the miR-7641/TPR axis to exacerbate neurologic damage caused by cerebral small vessel disease. Ann. Transl. Med. 9 (24), 1762.
Article CAS PubMed PubMed Central Google Scholar
Milluzzo A., Maugeri A., Barchitta M., Sciacca L., Agodi A. 2021. Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review. Int. J. Mol. Sci. 22 (19), 10502.
Article CAS PubMed PubMed Central Google Scholar
Wang S., Duan J., Liao J., Wang Y., Xiao X., Li L., Liu Y., Gu H., Yang P., Fu D., Du J., Li X., Shao M. 2022. LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis. Aging (Albany NY). 14 (16), 6809‒6828.
Article CAS PubMed PubMed Central Google Scholar
Kumar A., Datta M. 2022. H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes. Mol. Med. 28 (1), 81.
Article CAS PubMed PubMed Central Google Scholar
Yang W., Lyu Y., Xiang R., Yang J. 2022. Long noncoding RNAs in the pathogenesis of insulin resistance. Int. J. Mol. Sci. 23 (24), 16054.
Article CAS PubMed PubMed Central Google Scholar
Zhu X., Wu Y.B., Zhou J., Kang D.M. 2016. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem. Biophys. Res. Commun. 469 (2), 319‒325.
Article CAS PubMed Google Scholar
Unnikrishnan R., Pradeepa R., Joshi S.R., Mohan V. 2017. Type 2 diabetes: Demystifying the global epidemic. Diabetes. 66 (6), 1432‒1442.
Article CAS PubMed Google Scholar
Dedov I.I., Shestakova M.V., Mayorov A.Y., Mokryshiva N.G, Vikulova O.K., Galstain G.R., Shestako-va E.A. 2022. Standards of specialized diabetes care. Diabetes mellitus. 24 (1S), 1‒148.
Livak K.J., Schmittgen T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 25 (4), 402‒408.
Article CAS PubMed Google Scholar
Alrefai A.A., Khader H.F., Elbasuony H.A., Elzorkany K.M., Saleh A.A. 2023. Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus. Mol. Biol. Rep. 50 (7), 6075‒6085. https://doi.org/10.1007/s11033-023-08569-0
Article CAS PubMed Google Scholar
Taheri M., Eghtedarian R., Ghafouri-Fard S., Omrani M.D. 2023. Non-coding RNAs and type 2 diabetes mellitus. Arch. Physiol. Biochem. 129 (2), 526‒535.
Article CAS PubMed Google Scholar
Huang Y., Zhou Z., Zhang J., Hao Z., He Y., Wu Z., Song Y., Yuan K., Zheng S., Zhao Q., Li T., Wang B. 2021. lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell. J. Cell Mol. Med. 25 (15), 7135‒7145.
Article CAS PubMed PubMed Central Google Scholar
Tang H., Zhao L., Li M., Li T., Hao Y. 2019. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer. J. Cell. Biochem. 120 (4), 5055‒5061.
Article CAS PubMed Google Scholar
Liu C., Xu Y., Wu X., Zou Q. 2019. Clinical significance of linc00342 expression in the peripheral blood lymphocytes of patients with chronic kidney disease. Int. J. Nephrol. Renovasc. Dis. 12, 251‒256.
留言 (0)